These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29944372)
21. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis. Urban M; Šlachtová V; Brulíková L Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979 [TBL] [Abstract][Full Text] [Related]
22. Indoleamides are active against drug-resistant Mycobacterium tuberculosis. Lun S; Guo H; Onajole OK; Pieroni M; Gunosewoyo H; Chen G; Tipparaju SK; Ammerman NC; Kozikowski AP; Bishai WR Nat Commun; 2013; 4():2907. PubMed ID: 24352433 [TBL] [Abstract][Full Text] [Related]
23. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis. Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737 [TBL] [Abstract][Full Text] [Related]
24. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706 [TBL] [Abstract][Full Text] [Related]
25. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates. Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635 [TBL] [Abstract][Full Text] [Related]
26. Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against Dey R; Nandi S; Samadder A; Saxena A; Saxena AK Curr Top Med Chem; 2020; 20(29):2662-2680. PubMed ID: 32885754 [TBL] [Abstract][Full Text] [Related]
27. Exploiting the synthetic lethality between terminal respiratory oxidases to kill Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis. Thanna S; Knudson SE; Grzegorzewicz A; Kapil S; Goins CM; Ronning DR; Jackson M; Slayden RA; Sucheck SJ Org Biomol Chem; 2016 Jul; 14(25):6119-6133. PubMed ID: 27251120 [TBL] [Abstract][Full Text] [Related]